Background Outcomes in children and adolescents with recurrent or progressive high-grade
glioma are poor, with a historical median overall survival of 5.6 months. Pediatric high-…

Personalized cancer vaccines targeting patient-specific neoantigens are a promising
cancer treatment modality; however, neoantigen physicochemical variability can present …

Neural stem cell (NSC) transplantation can influence immune responses and suppress
inflammation in the CNS. Metabolites, such as succinate, modulate the phenotype and function of …

Neural stem cell (NSC) transplantation induces recovery in animal models of central nervous
system (CNS) diseases. Although the replacement of lost endogenous cells was originally …

Multiple sclerosis is one of the most common causes of chronic neurological disability
beginning in early to middle adult life. Multiple sclerosis is idiopathic in nature, yet increasing …

Tumor microenvironments are the result of cellular alterations in cancer that support unrestricted
growth and proliferation and result in further modifications in cell behavior, which are …

Immunotherapy failures can result from the highly suppressive tumour microenvironment
that characterizes aggressive forms of cancer such as recurrent glioblastoma (rGBM) 1 , 2 . …

Extracellular vesicles (EVs) are membrane particles involved in the exchange of a broad
range of bioactive molecules between cells and the microenvironment. Although it has been …

Ischemic stroke continues to be a leading cause of morbidity and mortality throughout the
world. To protect and/or repair the ischemic brain, a multitiered approach may be centered on …

Malignant brain tumors constitute nearly one-third of cancer diagnoses in children and have
recently surpassed hematologic malignancies as the most lethal neoplasm in the pediatric …